Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12569560 | Bismuth-gadolinium nanoparticles | 🖼🧊📄§ | 2026-03-10 | 2043-01-24 | 0 | 31 |
| 12569558 | Composite adjuvant system and method for preparing adjuvant | 🖼🧊📄§ | 2026-03-10 | 2040-06-24 | 0 | 31 |
| 12569554 | Triterpene saponin analogues | 🖼🧊📄§ | 2026-03-10 | 2038-04-25 | 0 | 31 |
| 12569557 | Targeting moDC to enhance vaccine efficacy on mucosal surface | 🖼🧊📄§ | 2026-03-10 | 2039-09-27 | 0 | 31 |
| 12569552 | Fusion protein of pentamer and gB of cytomegalovirus, and vaccine containing said fusion protein | 🖼🧊📄§ | 2026-03-10 | 2041-06-08 | 0 | 31 |
| 12569553 | Shingles vaccines comprising a TLR9 agonist | 🖼🧊📄§ | 2026-03-10 | 2041-03-09 | 0 | 31 |
| 12569550 | Hemagglutinin modifications for improved influenza vaccine production | 🖼🧊📄§ | 2026-03-10 | 2041-09-01 | 0 | 31 |
| 12569549 | Flavivirus vaccine | 🖼🧊📄§ | 2026-03-10 | 2044-01-04 | 0 | 31 |
| 12569546 | Neoantigen immunotherapies | 🖼🧊📄§ | 2026-03-10 | 2040-06-11 | 0 | 31 |
| 12569545 | Method for treating and/or improving inflammatory intestinal disease | 🖼🧊📄§ | 2026-03-10 | 2043-05-24 | 0 | 31 |
| 12569547 | Immunogenic compositions against Clostridioides (Clostridium) difficile and methods thereof | 🖼🧊📄§ | 2026-03-10 | 2041-06-17 | 0 | 31 |
| 12569541 | Stem cells for transplantation and manufacturing method therefor | 🖼🧊📄§ | 2026-03-10 | 2040-03-17 | 0 | 31 |
| 12569538 | DPEP-1 binding compositions and methods of use | 🖼🧊📄§ | 2026-03-10 | 2043-06-05 | 0 | 31 |
| 12569539 | Adipocytes over-expressing FFAR4 and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-05-26 | 0 | 31 |
| 12569535 | Compositions and methods for enhancing systemic deliverability, tolerability, and efficacy of cationic macrocyclic peptides | 🖼🧊📄§ | 2026-03-10 | 2039-10-09 | 0 | 31 |
| 12569536 | Macrocyclic peptides for targeted inhibition of autophagy | 🖼🧊📄§ | 2026-03-10 | 2040-01-30 | 0 | 31 |
| 12569532 | Brain function regulating agent, and food or beverage product containing same | 🖼🧊📄§ | 2026-03-10 | 2042-09-16 | 0 | 31 |
| 12569528 | Methods for making botanical extract composition | 🖼🧊📄§ | 2026-03-10 | 2044-02-09 | 0 | 31 |
| 12569529 | Natural combination products and methods for regulation of kidney and excretory system function | 🖼🧊📄§ | 2026-03-10 | 2043-08-28 | 0 | 31 |
| 12569530 | Tannin-based antiproliferative pharmaceutical | 🖼🧊📄§ | 2026-03-10 | 2044-04-26 | 0 | 31 |
| 12569526 | Oncolytic virus platform to treat hematological cancer | 🖼🧊📄§ | 2026-03-10 | 2039-09-04 | 0 | 31 |
| 12569527 | Tetraselmis chuii (T. chuii) for the treatment of male infertility | 🖼🧊📄§ | 2026-03-10 | 2041-07-09 | 0 | 31 |
| 12569525 | Gene therapy for treating phenylketonuria | 🖼🧊📄§ | 2026-03-10 | 2042-06-06 | 0 | 31 |
| 12569520 | Immunity generation | 🖼🧊📄§ | 2026-03-10 | 2043-06-26 | 0 | 31 |
| 12569521 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | 🖼🧊📄§ | 2026-03-10 | 2044-04-22 | 0 | 31 |
| 12569517 | Method for treating osteoarthritis with mesenchymal stem cell exosomes | 🖼🧊📄§ | 2026-03-10 | 2040-02-07 | 0 | 31 |
| 12569514 | Stable, highly pure L-cysteine compositions for injection and methods of use | 🖼🧊📄§ | 2026-03-10 | 2045-01-06 | 0 | 31 |
| 12569511 | Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-01 | 0 | 31 |
| 12569504 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | 🖼🧊📄§ | 2026-03-10 | 2045-05-13 | 0 | 31 |
| 12569505 | Oral solid dosage forms comprising cannabinoids | 🖼🧊📄§ | 2026-03-10 | 2045-05-16 | 0 | 31 |
| 12569507 | CAR T-cells for the treatment of bone metastatic cancer | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12569510 | Antiviral prodrugs and pharmaceutical compositions thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12569500 | Combination comprising tricycle compound and use thereof in preparation of medicament for treating HBV | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12569496 | Treatment of cancer with a RAF inhibitor | 🖼🧊📄§ | 2026-03-10 | 2044-01-26 | 0 | 31 |
| 12569501 | Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions | 🖼🧊📄§ | 2026-03-10 | 2042-10-13 | 0 | 31 |
| 12569503 | Methods and compositions for substituted axially-chiral cannabinol analogs | 🖼🧊📄§ | 2026-03-10 | 2040-03-04 | 0 | 31 |
| 12569502 | Use of bile acids and derivatives thereof in preparation of GPR39 agonist | 🖼🧊📄§ | 2026-03-10 | 2040-10-30 | 0 | 31 |
| 12569499 | Intravenous formulations of RK-33 | 🖼🧊📄§ | 2026-03-10 | 2042-08-29 | 0 | 31 |
| 12569494 | Compositions and methods to promote thymic regeneration | 🖼🧊📄§ | 2026-03-10 | 2039-01-11 | 0 | 31 |
| 12569490 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-10 | 2045-01-31 | 0 | 31 |
| 12569492 | Immuno-therapeutic chemical compositions and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2045-07-24 | 0 | 31 |
| 12569489 | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase | 🖼🧊📄§ | 2026-03-10 | 2044-04-05 | 0 | 31 |
| 12569488 | Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients | 🖼🧊📄§ | 2026-03-10 | 2043-03-03 | 0 | 31 |
| 12569479 | Bupropion as a modulator of drug activity | 🖼🧊📄§ | 2026-03-10 | 2044-04-15 | 0 | 31 |
| 12569486 | Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | 🖼🧊📄§ | 2026-03-10 | 2044-02-13 | 0 | 31 |
| 12569483 | Methods for objective assessment of memory, early detection of risk for Alzheimer's disease, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs | 🖼🧊📄§ | 2026-03-10 | 2040-05-22 | 0 | 31 |
| 12569480 | Methods of treating fibrosis using compounds that promote glucose oxidation | 🖼🧊📄§ | 2026-03-10 | 2040-05-27 | 0 | 31 |
| 12569475 | Method for eradicating helicobacter pylori infection in patients regardless of body mass index | 🖼🧊📄§ | 2026-03-10 | 2043-12-07 | 0 | 31 |
| 12569476 | Piperidine urea derivatives for use as inotropic agents | 🖼🧊📄§ | 2026-03-10 | 2045-02-21 | 0 | 31 |
| 12569473 | Methods to treat respiratory infection utilizing castanospermine analogs | 🖼🧊📄§ | 2026-03-10 | 2043-07-05 | 0 | 31 |